YAKUGAKU ZASSHI · 1978 · 14 citations · 0 references
Natural SciencesChemistryMedicinal ChemistryBioorganic ChemistryOrganic ChemistrySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryHeterocyclic CompoundsOrganic SynthesisBioactive HeterocyclesBiological Activity FeaturesEscherichia ColiHeterocyclic MaterialsHeterocyclic Medicinal ChemistryMedicinal HeterocyclesPyrazole ChemistryPyrazole Synthesis
In order to examine the biological activity of furo [3, 2-c] pyrazole derivatives, synthesis of some such derivatives was carried out. Bromination of 5-methyl-1, 3-diphenylfuro-[3, 2-c] pyrazole gave the 5-bromomethyl compound (A) which was used as the starting material for the syntheses of 1, 3-diphenylfuro [3, 2-c] pyrazol-5-yl methyl ethers, 1, 3-diphenylfuro [3, 2-c] pyrazol-5-ylmethylamines, 1, 3-diphenylfuro [3, 2-c] pyrazole-5-acetic acid, and 1, 3-diphenylfuro [3, 2-c] pyrazol-5-ylvinylenes. Satisfactory antibacterial activity in vitro against Staphylococcus, Escherichia coli, Shigella flexneri, Mycobacterium tuberculosis, Candida albicans, and Trichophyton mentagrophytes was found in 5-methylaminomethyl-1, 3-diphenylfuro [3, 2-c] pyrazole, 5-(1-pyrrolidinylmethyl)-1, 3-diphenylfuro [3, 2-c] pyrazole, and 5-(4-methyl-1-piperazinylmethyl)-1, 3-diphenylfuro [3, 2-c] pyrazole.